Suresh Kumar

Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial

Arvinder S. Soin, Kuldeep Kumar, Narendra S. Choudhary et al. · The Lancet Respiratory Medicine · 2021 · 232 citations · Full text

A double‐blind, placebo‐controlled, randomised, clinical study on the effectiveness of collagen peptide on osteoarthritis

Suresh Kumar, Fumihito Sugihara, Keiji Suzuki et al. · Journal of the Science of Food and Agriculture · 2014 · 124 citations

Infection of Human Papillomavirus Type 18 and p53 Codon 72 Polymorphism in Lung Cancer Patients From India*

Neeraj Jain, Vikram Singh, Suresh Hedau et al. · CHEST Journal · 2005 · 60 citations

Codon 72, Human Papillomavirus Vaccines, Pathology +6

Efficacy of Novel Topical Liposomal Formulation of Cyclosporine in Mild to Moderate Stable Plaque Psoriasis

Rajiv Kumar, Sunil Dogra, Basant Amarji et al. · JAMA Dermatology · 2016 · 60 citations · Full text

Efficacy of Convalescent Plasma Therapy compared to Fresh Frozen Plasma in Severely ill COVID-19 Patients: A Pilot Randomized Controlled Trial

Meenu Bajpai, Suresh Kumar, Ashish Maheshwari et al. · 2020 · 59 citations · Full text

Convalescent Plasma, Fresh Frozen Plasma, Patient Safety +11